The single-use filtration assemblies market is aiming to achieve a significant valuation of USD 19.28 billion by 2033, ...

Less than 20 years after the first biopharmaceutical, insulin, was approved, a new generation of products is superseding replacement proteins and enzyme therapies in biotechnology's pipeline.

The bioprocess business of Asahi Kasei Medical comprises Planova™ virus removal filters and equipment used in the manufacturing process of biotherapeutic products such as biopharmaceuticals and ...